Free Newsletter
Stem cell agency forced to delay $58M in grants
The country's moribund bond market has forced California's stem cell agency to delay $58 million in new grants earmarked to train researchers, moments after the group approved them. Six San Francisco area labs, including one at Stanford University, will have to wait until March before the state agency can review the market and release the funds.
Board members have approved $700 million in grants so far, out of $3 billion approved by voters. But the California Institute for Regenerative Medicine says that the group has enough funds to meet its commitments through this September.
Meanwhile, the Los Angeles Times is reporting that Democrats and Republicans are competing for a top leadership position at CIRM. Democrats want Art Torres (photo), the outgoing chief of the California Democratic Party, to take the vice chairman's position at CIRM. But Governor Arnold Schwarzenegger is backing Republican biotech executive Duane Roth (photo). The dispute is growing particularly heated as the CIRM adds new salaries for its leaders.
- read the report in the San Francisco Chronicle
- read the story in the Los Angeles Times
Related Articles:
California stem cell agency faces cash crisis
California initiative triggers research spending boom
California- Top 5 Regions Targeting Biotech
CIRM offers $59M to inspire young scientists
California's stem cell boom spurs research bonanza
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: